Pinch-3 activators comprise a diverse set of chemical compounds that enhance the functional activity of Pinch-3 through intricate cellular signaling pathways. Forskolin, by increasing cAMP levels, indirectly augments the functional role of Pinch-3 in the assembly of focal adhesion complexes via PKA activation. Similarly, PMA, as a PKC activator, and LY294002, as a PI3K inhibitor, modulate downstream signaling cascades that influence the role of Pinch-3 within cell adhesion sites by altering the dynamics of these complexes. The MEK inhibitor U0126 and the p38 MAPK inhibitor SB203580 could shift equilibrium within the MAPK signaling pathways, supporting processes that enhance the activity of Pinch-3 in cell migration and adhesion. Genistein, through its inhibition of tyrosine kinases, and Sphingosine-1-phosphate, via its receptor-mediated signaling, can further potentiate the cellular mechanisms in which Pinch-3 is fundamental by modulating phosphorylation events and cytoskeletal organization.
The activity of Pinch-3 is also influenced by compounds that affect intracellular calcium levels and kinase activity. Thapsigargin and A23187 both enhance Pinch-3's role by modulating calcium signaling, whichis crucial for the regulation of focal adhesion dynamics and cellular contractility. Epigallocatechin gallate (EGCG), by inhibiting kinase activity, can lead to a reduction in competitive phosphorylation within adhesion complexes, indirectly enhancing the activity of Pinch-3. Staurosporine, albeit a broad-acting kinase inhibitor, might selectively activate Pinch-3-involved pathways by reducing the inhibition that specific kinases could exert on processes crucial for cell adhesion and morphology. Finally, Y-27632, a ROCK inhibitor, can alter actin cytoskeleton dynamics, further promoting the role of Pinch-3 in maintaining cell shape and facilitating cell movement. Collectively, these activators work through a variety of mechanisms to enhance the functional activity of Pinch-3, pivotal for its role in cellular adhesion, signaling, and migration without necessitating upregulation of its expression or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates intracellular cAMP levels, which in turn activates PKA. PKA phosphorylation can influence the focal adhesion assembly, where Pinch-3 is known to play a critical role in the formation and turnover of these complexes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in the regulation of cell adhesion and cytoskeletal organization. Pinch-3's role in focal adhesions suggests it could be functionally enhanced by PKC-mediated signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters downstream AKT signaling. By modifying this pathway, it could enhance the activity of Pinch-3 by affecting its interaction with integrin-linked kinase (ILK), a component of focal adhesions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, potentially shifting signaling dynamics to support pathways that enhance the activity of Pinch-3 in cellular adhesion and migration processes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that could potentiate the activity of Pinch-3 by reducing competitive phosphorylation events, thus favoring Pinch-3's role in cell adhesion and migration. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P engages with S1P receptors to activate downstream pathways including Rho and Rac, which can modulate the cytoskeleton and cell adhesion where Pinch-3 is crucial. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels, which can activate calcium-dependent signaling pathways. This can influence the focal adhesion and actin remodeling activities, potentially enhancing the function of Pinch-3. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that may influence cell adhesion pathways by reducing active phosphorylation, which could indirectly enhance the role of Pinch-3 in these pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium, thus activating signaling pathways crucial for cell adhesion where Pinch-3 is implicated. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor which, by inhibiting certain kinases, may selectively activate pathways involving Pinch-3, especially in the context of cell adhesion and spreading. | ||||||